{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:29Z","timestamp":1786654109890,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart &amp; Vasculature"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijcha.2026.101968","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:16:50Z","timestamp":1783091810000},"page":"101968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Strict carbohydrate restriction enables volume-based FDG-PET\/CT to outperform SUVmax for risk stratification in cardiac sarcoidosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Yoshimitsu","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yodogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ijcha.2026.101968_bb0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcha.2026.101968_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0020","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"6","key":"10.1016\/j.ijcha.2026.101968_bb0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0030","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch. Pathol. Lab Med."},{"issue":"7","key":"10.1016\/j.ijcha.2026.101968_bb0035","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"issue":"37","key":"10.1016\/j.ijcha.2026.101968_bb0040","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcha.2026.101968_bb0045","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm."},{"issue":"11","key":"10.1016\/j.ijcha.2026.101968_bb0050","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2026.101968_bb0060","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis","author":"Zhang","year":"2018","journal-title":"Can. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101968_bb0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2214\/AJR.07.3089","article-title":"MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function","volume":"191","author":"Ichinose","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101968_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcha.2026.101968_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0080","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.ijcha.2026.101968_bb0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.ijcha.2026.101968_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2 Pt 2","key":"10.1016\/j.ijcha.2026.101968_bb0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J. Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2026.101968_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J. Nucl. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT, including extracardiac sites of disease, as predictors of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101968_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.ijcha.2026.101968_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J. Card. Fail."},{"issue":"5","key":"10.1016\/j.ijcha.2026.101968_bb0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2013.05.004","article-title":"Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet","volume":"62","author":"Kobayashi","year":"2013","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0145","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"issue":"11","key":"10.1016\/j.ijcha.2026.101968_bb0150","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono","year":"2022","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101968_bb0155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom. J."},{"issue":"6","key":"10.1016\/j.ijcha.2026.101968_bb0160","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-018-0447-8","article-title":"Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?","volume":"8","author":"Furuya","year":"2018","journal-title":"EJNMMI Res."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101968_bb0170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J. Nucl. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101968_bb0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: the optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2019","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J. Nucl. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcha.2026.101968_bb0185","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"10","key":"10.1016\/j.ijcha.2026.101968_bb0190","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"36","key":"10.1016\/j.ijcha.2026.101968_bb0195","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101968_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcmg.2023.05.017","article-title":"Prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation: the PRESTIGE study","volume":"17","author":"Morimoto","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"6","key":"10.1016\/j.ijcha.2026.101968_bb0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jcmg.2024.01.010","article-title":"Prognostic value of combined assessments of late gadolinium enhancement and fluorodeoxyglucose uptake in cardiac sarcoidosis","volume":"17","author":"Kazui","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2026.101968_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132686","article-title":"Reduced 18F-FDG uptake in the basal interventricular septum as a predictor of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis","volume":"419","author":"Takeuchi","year":"2025","journal-title":"Int. J. Cardiol."}],"container-title":["IJC Heart &amp; Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:23:38Z","timestamp":1786652618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S2352906726001028"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101968","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strict carbohydrate restriction enables volume-based FDG-PET\/CT to outperform SUVmax for risk stratification in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101968"}}